Thrivent Financial for Lutherans

Position in KRYS — Krystal Biotech, Inc.

CIK 314984 Minneapolis, MN

Position in KRYS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$6,403,502

+$1,953,682 QoQ

Shares Held

17,229

+0.0% QoQ

Ownership

0.058%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#93

of 416 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Thrivent Financial for Lutherans holds $348,973,073 across 50 Biotechnology names. KRYS ranks #8 (1.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	1,620,743	$88,184,625
2	REGN	Regeneron Pharmaceuticals, Inc.	131,457	$81,968,697
3	RPRX	Royalty Pharma plc	740,772	$41,535,085
4	JAZZ	Jazz Pharmaceuticals plc	80,500	$19,398,084
5	ARGX	Argenx SE	12,688	$11,771,545
6	VRTX	Vertex Pharmaceuticals Inc / Ma	20,169	$10,018,546
7	VCEL	Vericel Corp	170,272	$7,575,400
8	KRYS	Krystal Biotech, Inc. This page	17,229	$6,403,502

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,403,502	17,229	+0.0%	Shares	Sole	2026-08-14
2026-03-31	$4,449,820	17,226	-2.9%	Shares	Sole	2026-05-01
2025-12-31	$4,372,140	17,734	-4.6%	Shares	Sole	2026-02-05
2025-09-30	$3,280,633	18,584	-0.6%	Shares	Sole	2025-11-04
2025-06-30	$2,570,502	18,700	+0.6%	Shares	Sole	2025-08-26
2025-03-31	$3,351,777	18,590	-5.0%	Shares	Sole	2025-08-26
2024-12-31	$3,064,739	19,563	-1.5%	Shares	Sole	2025-02-10
2024-09-30	$3,614,023	19,854	-3.7%	Shares	Sole	2024-11-07
2024-06-30	$3,787,575	20,625	—	Shares	Sole	2024-08-13
No filing history on record for this holder in this stock.